Abstract: An aluminum alloy powder metal is disclosed. A sintered part made from the aluminum alloy powder has a thermal conductivity comparable to or exceeding parts made from wrought aluminum materials.

Abstract: A transition element-doped aluminum powder metal and a method of making this powder metal are disclosed. The method of making includes forming an aluminum-transition element melt in which a transition element content of the aluminum-transition element melt is less than 6 percent by weight. The aluminum-transition element melt then powderized to form a transition element-doped aluminum powder metal. The powderization may occur by, for example, air atomization.

Abstract: The “Forced Way” method is a unique method of generating variable ratio outputs from a given input of constant rotational speed by forcing one end of a drive shaft to follow a continuous path (way) around a given circle at a constant speed that can then be deformed into curves of varying radiuses that would range from the radius of the given circle to that of the various radiuses (arcs) of various ovals to a final shape of an oblong. Forcing the end of the drive shaft to follow these shapes would result in the drive shaft rotating at different rotational speeds as it transverses the shape. By sampling only the rotational output while moving over the desired portion of the shape one can control the output's rotational speed which will be some ratio of the input. The “Forced Way” method is the only method of continuously varying an output that is robust enough to be used in any vehicle with NO possibility of slipping.

Abstract: A zirconium-doped aluminum powder metal and a method of making this powder metal are disclosed. The method of making includes forming an aluminum-zirconium melt in which a zirconium content of the aluminum-zirconium melt is less than 2.0 percent by weight. The aluminum-zirconium melt then powderized to form a zirconium-doped aluminum powder metal. The powderization may occur by, for example, air atomization.

Abstract: The Harmonic Accumulation and Relative Transference of Kinetic Energy method does not transmit, but rather, transfers torque/energy from a power source to a driven system of higher rotational speed through the use of an oscillating flywheel and a potential energy storage device, for example, a torsion spring The power source adds energy to the oscillating flywheel by applying an impulse torque to the flywheel just as the flywheel begins to start rotating, and then transfers that energy to the driven system when the flywheel's speed (which may be its highest rotational speed) matches that of the driven system's rotational speed and direction. Thus, the energy is transferred when the flywheel and the driven system are at 0 rpm “relative” to each other. Accordingly, the impulse torques may be applied using principles of electric motors.

Abstract: An improved handrail for a staircase or ramp. In one embodiment, the handrail includes an elongated member such as a cylinder or bar that spans the length of the staircase or ramp and a riser barrier. The riser barrier has an extender portion and a riser portion. The extender portion of the riser barrier keeps the elongated member a sufficient distance horizontally from the riser portion that a person can slide his or her hand on the rail without interference. The riser portion projects vertically a sufficient distance above the elongated member to deter sliding down the elongated member. Thus, sliding on the member is deterred, while the function of the cylinder as a handrail is preserved.

Abstract: A powder metal mixture is disclosed that provides improved mechanical properties for parts made from powder metal, such as cam caps. The powder metal mixture, upon sintering, forms an S phase intermetallic in the Al—Cu—Mg alloy system. The S phase is present in a concentration that results in an enhanced response to cold work strengthening of the powder metal part. Further, by minor adjustments to certain alloy elements, such as tin, the tensile properties of the resultant part may be adjusted.

Abstract: The “Forced Way” method is a unique method of generating variable ratio outputs from a given input of constant rotational speed by forcing one end of a drive shaft to follow a continuous path (way) around a given circle at a constant speed that can then be deformed into curves of varying radiuses that would range from the radius of the given circle to that of the various radiuses (arcs) of various ovals to a final shape of an oblong. Forcing the end of the drive shaft to follow these shapes would result in the drive shaft rotating at different rotational speeds as it transverses the shape. By sampling only the rotational output while moving over the desired portion of the shape one can control the output's rotational speed which will be some ratio of the input. The “Forced Way” method is the only method of continuously varying an output that is robust enough to be used in any vehicle with NO possibility of slipping.

Abstract: There is disclosed a method for treating textiles comprising applying to the textile an enzyme having a specific activity towards the textile, under conditions such that there is substantially no mechanical agitation.

Abstract: A system and method for managing gas bubbles in a liquid flow system are described. In particular, according to the system and method, novel techniques reduce a volume of cavities in the liquid flow system and limit a cross-sectional area of the liquid flow system to a maximum cross-sectional area of tolerably sized bubbles. In this manner, by reducing the cavity volumes and limiting cross-sectional areas, the formation of intolerably sized bubbles and the aggregation of tolerably sized bubbles into intolerably sized bubbles are each substantially prevented. Also, bubbles may be removed from the system to reduce the quantity of bubbles that are to be managed.

Abstract: There is disclosed a method for treating textiles comprising applying to the textile an enzyme having a specific activity towards the textile, under conditions such that there is substantially no mechanical agitation.

Abstract: There is provided the use of an agent that promotes class III SLRP activity in the manufacture of a medicament for the prevention and/or treatment of cancer. Such medicaments may be used in the treatment of tumours, including avascular tumours. Suitable agents to be used may preferably include the class III SLRPs opticin; epiphycan; or mimecan. The invention also provides a method for the prevention and/or treatment of cancer.

Abstract: The present invention provides novel uses two members of a new family of human proteins, designated as “Zven,” as agents that stimulate gastrointestinal contractility, gastric emptying, intestinal transit, and treating gastroparesis The Zven1 gene, which resides in human chromosome 3p21.1-3p14.3, is expressed in testicular tissue and peripheral blood lymphocytes. The invention also provides methods for using the antibodies to detect the presence of the protein with antibodies and methods for using the polynucleotides to detect the presence of Zven RNA.

Abstract: A rich client view of server data is integrated within a server presentation of data provided by a portal server application. The rich client view of data is included with other web based views provided according to the server presentation of data when the rich client view is created. The rich client view is integrated among the web based views such that the rich client view and web based views are organized together. A separate application is launched to render the rich client view in response to a selection to render the rich client view. The selection to render the rich client view is integrated within the server presentation of data such that rich client view is provided seamlessly within the server presentation.

Abstract: The present invention provides novel uses two members of a new family of human proteins, designated as “Zven,” as agents that stimulate gastrointestinal contractility, gastric emptying, intestinal transit, and treating gastroparesis The Zven1 gene, which resides in human chromosome 3p21.1-3p14.3, is expressed in testicular tissue and peripheral blood lymphocytes. The invention also provides methods for using the antibodies to detect the presence of the protein with antibodies and methods for using the polynucleotides to detect the presence of Zven RNA.

Abstract: The present invention provides novel uses two members of a new family of human proteins, designated as “Zven,” as agents that stimulate gastrointestinal contractility, gastric emptying, intestinal transit, and treating gastroparesis The Zven1 gene, which resides in human chromosome 3p21.1 - 3p14.3, is expressed in testicular tissue and peripheral blood lymphocytes. The invention also provides methods for using the antibodies to detect the presence of the protein with antibodies and methods for using the polynucleotides to detect the presence of Zven RNA.

Abstract: The present invention provides novel uses two members of a new family of human proteins, designated as “Zven,” as agents that stimulate gastrointestinal contractility, gastric emptying, intestinal transit, and treating gastroparesis The Zven1 gene, which resides in human chromosome 3p21.1-3p14.3, is expressed in testicular tissue and peripheral blood lymphocytes. The invention also provides methods for using the antibodies to detect the presence of the protein with antibodies and methods for using the polynucleotides to detect the presence of Zven RNA.

Abstract: The present invention provides novel uses two members of a new family of human proteins, designated as “Zven,” as agents that stimulate gastrointestinal contractility, gastric emptying, intestinal transit, and treating gastroparesis The Zven1 gene, which resides in human chromosome 3p21.1-3p14.3, is expressed in testicular tissue and peripheral blood lymphocytes. The invention also provides methods for using the antibodies to detect the presence of the protein with antibodies and methods for using the polynucleotides to detect the presence of Zven RNA.

Abstract: A patient having hemophilia A is treated by administering factor XIII generally in conjunction with factor VIII or desmopressin.